Guardant Health, Inc. Common Stock (GH) is a publicly traded Healthcare sector company. As of May 20, 2026, GH trades at $112.54 with a market cap of $12.68B and a P/E ratio of -33.50. GH moved +17.08% today. Year to date, GH is +12.86%; over the trailing twelve months it is +187.64%. Its 52-week range spans $20.14 to $120.74. Analyst consensus is strong buy with an average price target of $128.88. Rallies surfaces GH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Guardant Health, Inc. Common Stock (GH) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GH moved +17.08% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $112.54 |
| Market Cap | $12.68B |
| P/E Ratio | -33.50 |
| EPS | $-3.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $120.74 |
| 52-Week Low | $20.14 |
| Volume | 4.14M |
| Avg Volume | 0 |
| Revenue (TTM) | $982.02M |
| Net Income | $-416.28M |
| Gross Margin | 64.46% |
19 analysts cover GH: 0 strong buy, 18 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $128.88.